| Gene symbol | CD79B | Synonyms | AGM6, B29, IGB, Igbeta | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q23.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | CD79b molecule | ||||
| GTO ID | GTC2982 |
| Trial ID | NCT05312476 |
| Disease | B-Cell Non-Hodgkin's Lymphoma |
| Altered gene | IGB |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | Igβ CAR-T cells |
| Phase | Phase2 |
| Recruitment status | Recruiting |
| Title | Clinical Study on CAR-T Targeting Igβ Targets in Refractory Relapsed Non-Hodgkin's Lymphoma |
| Year | 2022 |
| Country | China |
| Company sponsor | The First Affiliated Hospital of Soochow University |
| Other ID(s) | R/R B-NHL 02 |
| Cohort 1 | |||||||||
|
|||||||||